Prognostic Stage IV Breast Cancer AJCC v8 Completed Phase 1 Trials for Durvalumab (DB11714)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03544125Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast CancerTreatment